Impact BioMedical Inc (AMEX: IBO) Drops -25.14% In Early Trade; What Lies Ahead?

RLX

Impact BioMedical Inc (AMEX:IBO) price closed lower on Tuesday, April 08, and dropping -25.14% below its previous close.

A look at the daily price movement shows that the last close reads $0.87, with intraday deals fluctuated between $0.6 and $0.9154. Taking into account the 52-week price action we note that the stock hit a 52-week high of $6.17 and 52-week low of $0.46. The stock subtracted -24.15% on its value in the past month.

Impact BioMedical Inc, which has a market valuation of $7.47 million, is expected to release its quarterly earnings report in May.

Technical indicators in stocks provide crucial insights into market trends, guiding investors with precise entry and exit points based on price movements for informed decision-making.

The overview shows that IBO’s price is at present -54.84% off the SMA20 and -60.00% from the SMA50. The Relative Strength Index (RSI) metric on the 14-day timeframe is pointing at 42.74, with weekly volatility standing at 32.57%. The indicator jumps to 63.37% when calculated based on the past 30 days. Impact BioMedical Inc (AMEX:IBO)’s beta value is holding at 0, while the average true range (ATR) indicator is currently reading 0.64.

An analysis of the Impact BioMedical Inc (AMEX:IBO) stock in terms of its daily trading volume indicates that the 3-month average is 5.98 million. However, this figure increases on the past 10-day timeline to an average of 18.38 million.

Current records show that the company has 11.50M in outstanding shares. The insiders’ percentage holdings are 51.49% of outstanding shares while the percentage share held by institutions stands at 0.77%. The stats also highlight that short interest as of 2025-03-14, stood at 9001.0 shares, which puts the short ratio at the time at 0.3. Notably, we see that shares short in March fall slightly given the previous month’s figure stood at 12105.0. But the -55.17% downside, the stock’s price has registered year-to-date as of last trading, will likely reignite investor interest given the prospect of it rallying even higher.

Most Popular